id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1993-N-0043-0002,FDA,FDA-1993-N-0043,Adverse Experience Reporting Requirements for Human Drug and Licensed Biological Products; Correction,Notice,Correction,1994-12-05T05:00:00Z,1994,12,,,2024-04-29T14:48:41Z,,0,0,09000064804fc3bb
FDA-1993-N-0043-0001,FDA,FDA-1993-N-0043,Adverse Experience Reporting Requirements for Human Drug and Licensed Biological Products,Notice,NPR-Notice of Proposed Rule-Making,1994-11-15T05:00:00Z,1994,11,1994-11-15T05:00:00Z,1995-01-26T04:59:59Z,2024-04-29T14:42:48Z,,0,0,09000064804fc3b4
FDA-1993-N-0043-0009,FDA,FDA-1993-N-0043,Background Material,Supporting & Related Material,BKG-Background Material,1994-10-26T04:00:00Z,1994,10,,,2008-05-16T23:24:08Z,,0,0,09000064804fc45c
FDA-1993-N-0043-0011,FDA,FDA-1993-N-0043,Background Material,Supporting & Related Material,BKG-Background Material,1994-10-26T04:00:00Z,1994,10,,,2008-05-16T23:24:08Z,,0,0,09000064804fc45e
FDA-1993-N-0043-0008,FDA,FDA-1993-N-0043,Background Material,Supporting & Related Material,BKG-Background Material,1994-10-26T04:00:00Z,1994,10,,,2008-05-16T23:24:10Z,,0,0,09000064804fc45b
FDA-1993-N-0043-0012,FDA,FDA-1993-N-0043,Background Material,Supporting & Related Material,BKG-Background Material,1994-10-26T04:00:00Z,1994,10,,,2008-05-16T23:24:10Z,,0,0,09000064804fc45f
FDA-1993-N-0043-0010,FDA,FDA-1993-N-0043,Background Material,Supporting & Related Material,BKG-Background Material,1994-10-26T04:00:00Z,1994,10,,,2008-05-16T23:24:09Z,,0,0,09000064804fc45d